Stone Ridge Asset Management’s iRadimed IRMD Stock Holding History

Stone Ridge Asset Management’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-17,598	Closed	-$408K	–	238
2020 Q2	$408K	Sell	17,598 -8,543	-33%	-$183K	0.07%	332
2020 Q1	$558K	Hold	26,141	–	–	0.06%	353
2019 Q4	$611K	Hold	26,141	–	–	0.04%	573
2019 Q3	$549K	Hold	26,141	–	–	0.03%	657
2019 Q2	$535K	Hold	26,141	–	–	0.03%	693
2019 Q1	$734K	Hold	26,141	–	–	0.04%	550
2018 Q4	$639K	Hold	26,141	–	–	0.04%	659
2018 Q3	$971K	Hold	26,141	–	–	0.05%	496
2018 Q2	$542K	Hold	26,141	–	–	0.03%	746
2018 Q1	$369K	Hold	26,141	–	–	0.02%	942
2017 Q4	$396K	Buy	+26,141	New	+$332K	0.02%	928

Other funds holding IRMD

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

RCMC

RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Stone Ridge Asset Management's IRMD Position: Q3 2020 in Review

Stone Ridge Asset Management sold out of iRadimed (IRMD) in Q3 2020, closing a stake of 17,598 shares — an estimated $408K sold.

Stone Ridge Asset Management first reported a position in IRMD in Q4 2017 and held it in 11 quarters. The position peaked at $971K in Q3 2018. 62 funds tracked by Wall St. Rank hold IRMD as of Q3 2020.

Stone Ridge Asset Management reported no remaining iRadimed position as of Q3 2020 after selling out during the quarter.
Stone Ridge Asset Management sold 17,598 iRadimed shares in Q3 2020, an estimated $408K.
Stone Ridge Asset Management first reported a position in iRadimed in Q4 2017 and held it in 11 quarters.
Stone Ridge Asset Management's iRadimed position peaked at $971K in Q3 2018.
62 funds tracked by Wall St. Rank held iRadimed as of Q3 2020.

Based on Stone Ridge Asset Management's 13F filing for Q3 2020.